Results 21 to 30 of about 8,310 (206)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan

open access: yesJapanese Dental Science Review, 2019
Summary: Since Marx reported on osteonecrosis of the jaw caused by the injectable bisphosphonates (BPs) pamidronate and zoledronate, there have been numerous reports not only in Western countries, but in Japan as well, of bisphosphonate-related ...
Takahiko Shibahara
doaj   +1 more source

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study

open access: yesBalkan Journal of Dental Medicine, 2021
Background/Aim: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) was first introduced in 2003 and its scope was expanded by the name medication-related osteonecrosis of the jaw (MRONJ), since 2014.
Karapinar Gökay   +3 more
doaj   +1 more source

Challenges and Controversies in the Diagnosis of MRONJ [PDF]

open access: yes, 2019
Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but potentially seriousand debilitating complication [...
Campisi, Giuseppina, Fede, Olga Di
core   +1 more source

The dental management of patients at risk of medication-related osteonecrosis of the jaw: New paradigm of primary prevention [PDF]

open access: yes, 2018
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition that can considerably affect the quality of life of patients ...
Bedogni, Alberto   +7 more
core   +2 more sources

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)

open access: yesJapanese Dental Science Review, 2019
Summary: Generally, CT and MR images of antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-related osteonecrosis of the jaw (MRONJ) show nonspecific findings as seen in active osteomyelitis.However, there are some characteristics as
Akira Baba   +6 more
doaj   +1 more source

Medication-related osteonecrosis of the jaw: clinical and practical guidelines [PDF]

open access: yes, 2016
Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse drug reaction, consisting of progressive bone destruction in the maxillofacial region of patients.
Allen   +42 more
core   +2 more sources

Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study [PDF]

open access: yes, 2018
Introduction: The management of bisphosphonate-related osteonecrosis of the jaw (BRONJ), with no evidence-based guidelines, remains controversial. We aimed to evaluate the efficiency of a conservative surgical treatment combining Er,Cr:YSGG laser and ...
Albanese, Antonino   +10 more
core   +1 more source

Osteonecrosis of The Jaw; Medication- Related Osteonecrosis of the jaw (MRONJ)

open access: yesSONDE (Sound of Dentistry), 2021
Sejak tahun 2004, dilaporkan terjadinya osteonecrosis of the jaw pada pasien osteoporosis yang mengkonsumsi bifosfonat, walaupun hal tersebut lebih sedikir dibandingkan kejadian osteonecrosis of the jaw pada penderita kanker yang mendapat terapi bifosfonat secara intravena.
openaire   +2 more sources

Dental extraction following zoledronate, induces osteonecrosis in rat´s jaw [PDF]

open access: yes, 2017
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) is clinically characterized by the presence of exposed bone in the oral cavity that persists for more than eight weeks.
Gaitán Cepeda, Luis Alberto   +2 more
core   +1 more source

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report

open access: yesCase Reports in Clinical Practice, 2023
Medication-related osteonecrosis of the jaw (MRONJ) is a side effect of anti-bone resorption medications. Nowadays antiresorptive medications like bisphosphonate and monoclonal antibodies like denosumab that have been prescribed for bone disorders and ...
Maryam Jalili Sadrabad, Elham Saberian
doaj   +1 more source

Home - About - Disclaimer - Privacy